RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS

Aim. To evaluate the prevalence of covert visceral adiposity (CVA) in males with type 2 diabetes (DM2) and to assess its relation with subclinical atherosclerosis and food-related behavior.Material and methods. To the study, 72 middle age males included (54,1±0,7 y.o.). Mean duration of DM25,1±1,1 y...

Full description

Bibliographic Details
Main Authors: A. Е. Filippov, A. A. Sergoventsev, B. V. Pomogaibo
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2018-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/597
_version_ 1797882495064080384
author A. Е. Filippov
A. A. Sergoventsev
B. V. Pomogaibo
author_facet A. Е. Filippov
A. A. Sergoventsev
B. V. Pomogaibo
author_sort A. Е. Filippov
collection DOAJ
description Aim. To evaluate the prevalence of covert visceral adiposity (CVA) in males with type 2 diabetes (DM2) and to assess its relation with subclinical atherosclerosis and food-related behavior.Material and methods. To the study, 72 middle age males included (54,1±0,7 y.o.). Mean duration of DM25,1±1,1 years. In 28 patients DM2 had been diagnosed first time in the study. Those with body mass index (BMI) >30 kg/m2 and waist circumference >102 cm were excluded. All patients underwent standard clinical investigations and additionally, leptin levels measurement in blood serum, with bioelectrical impedance measurement of adipous tissue amount, duplex scan of carotid and femoral arteries; the EAT-26 questionnaire was applied.Results. In the group of participants, CVA prevalence was 31%. In this group of patients there were significantly higher BMI, waist circumference low density lipoproteides levels and leptin. At atherosclerosis assessment in carotid and femoral arteries, CVA associated with more significant and multifocal lesion. In regression analysis, the sum of plaques number correlated with the age, BMI, systolic blood pressure, low density lipoproteides levels.Conclusion. CVA might have significance in the increase of cardiovascular risk in middle aged males with normal BMI and with no obesity.
first_indexed 2024-04-10T03:35:38Z
format Article
id doaj.art-db5c5d4e45b14f79984990ef4bb9b489
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:35:38Z
publishDate 2018-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-db5c5d4e45b14f79984990ef4bb9b4892023-03-13T07:23:26Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252018-02-01171495310.15829/1728-8800-2018-1-49-53533RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTSA. Е. Filippov0A. A. Sergoventsev1B. V. Pomogaibo2ФГБОУ ВО Санкт-Петербургский государственный университетФКУ Центральный военный клинический госпиталь им. П.В. Мандрыка Министерства обороны Российской ФедерацииФГКУ 413 военный госпиталь Министерства обороны Российской ФедерацииAim. To evaluate the prevalence of covert visceral adiposity (CVA) in males with type 2 diabetes (DM2) and to assess its relation with subclinical atherosclerosis and food-related behavior.Material and methods. To the study, 72 middle age males included (54,1±0,7 y.o.). Mean duration of DM25,1±1,1 years. In 28 patients DM2 had been diagnosed first time in the study. Those with body mass index (BMI) >30 kg/m2 and waist circumference >102 cm were excluded. All patients underwent standard clinical investigations and additionally, leptin levels measurement in blood serum, with bioelectrical impedance measurement of adipous tissue amount, duplex scan of carotid and femoral arteries; the EAT-26 questionnaire was applied.Results. In the group of participants, CVA prevalence was 31%. In this group of patients there were significantly higher BMI, waist circumference low density lipoproteides levels and leptin. At atherosclerosis assessment in carotid and femoral arteries, CVA associated with more significant and multifocal lesion. In regression analysis, the sum of plaques number correlated with the age, BMI, systolic blood pressure, low density lipoproteides levels.Conclusion. CVA might have significance in the increase of cardiovascular risk in middle aged males with normal BMI and with no obesity.https://cardiovascular.elpub.ru/jour/article/view/597абдоминальное ожирениеатеросклерозпищевое поведениесахарный диабет 2 типа
spellingShingle A. Е. Filippov
A. A. Sergoventsev
B. V. Pomogaibo
RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
Кардиоваскулярная терапия и профилактика
абдоминальное ожирение
атеросклероз
пищевое поведение
сахарный диабет 2 типа
title RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
title_full RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
title_fullStr RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
title_full_unstemmed RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
title_short RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
title_sort relation of covert visceral adiposity and subclinical atherosclerosis presentation in type 2 diabetes male patients
topic абдоминальное ожирение
атеросклероз
пищевое поведение
сахарный диабет 2 типа
url https://cardiovascular.elpub.ru/jour/article/view/597
work_keys_str_mv AT aefilippov relationofcovertvisceraladiposityandsubclinicalatherosclerosispresentationintype2diabetesmalepatients
AT aasergoventsev relationofcovertvisceraladiposityandsubclinicalatherosclerosispresentationintype2diabetesmalepatients
AT bvpomogaibo relationofcovertvisceraladiposityandsubclinicalatherosclerosispresentationintype2diabetesmalepatients